HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas Schirrmann Selected Research
Thomas Schirrmann Research Topics
Disease
13
Neoplasms (Cancer)
01/2021 - 04/2002
3
Infections
11/2021 - 01/2011
3
Lymphoma (Lymphomas)
04/2014 - 04/2008
2
Communicable Diseases (Infectious Diseases)
01/2021 - 02/2009
2
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 10/2016
2
COVID-19
01/2021 - 01/2021
2
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2014 - 01/2012
2
Inflammation (Inflammations)
01/2013 - 01/2012
1
Tetanus
01/2021
1
Diphtheria
01/2021
1
Chronic Disease (Chronic Diseases)
10/2016
1
Adenocarcinoma
09/2016
1
Pathologic Processes
01/2016
1
Confusion (Bewilderment)
01/2016
1
Human Influenza (Influenza)
11/2015
1
Hodgkin Disease (Hodgkin's Disease)
04/2014
1
Hematologic Neoplasms (Hematological Malignancy)
04/2014
1
Paralysis (Palsy)
03/2014
1
Bacterial Infections (Bacterial Infection)
01/2013
1
T-Cell Lymphoma (Lymphoma, T Cell)
01/2012
1
Neuroblastoma
01/2012
1
Carcinoma (Carcinomatosis)
01/2011
1
Pneumonia (Pneumonitis)
09/2008
1
Myeloid Leukemia (Leukemia, Myelocytic)
03/2005
Drug/Important Bio-Agent (IBA)
12
Antibodies
IBA
01/2021 - 01/2009
6
Proteins (Proteins, Gene)
FDA Link
01/2021 - 04/2008
3
Neutralizing Antibodies
IBA
11/2021 - 05/2014
3
Immunoglobulin G (IgG)
IBA
01/2021 - 01/2011
3
Monoclonal Antibodies
IBA
10/2016 - 01/2012
3
Immunoglobulins (Immunoglobulin)
IBA
03/2014 - 04/2002
2
Pancreatic Ribonuclease (Ribonuclease A)
IBA
01/2018 - 03/2014
2
Antigens
IBA
01/2018 - 03/2014
2
Ribonucleases (Ribonuclease)
IBA
01/2018 - 04/2008
2
Peptides (Polypeptides)
IBA
01/2012 - 09/2008
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
03/2005 - 04/2002
1
Immunoglobulin Fragments
IBA
01/2021
1
Recombinant DNA (Recombinant DNA Research)
IBA
10/2016
1
Cyclin-Dependent Kinase 4
IBA
01/2016
1
Pharmaceutical Preparations
IBA
01/2016
1
Inosine Monophosphate (IMP)
IBA
11/2015
1
HLA-A*02:01 antigen
IBA
11/2015
1
Immunotoxins (Immunotoxin)
IBA
04/2014
1
Brentuximab Vedotin
IBA
04/2014
1
Immunoconjugates (Immunoconjugate)
IBA
04/2014
1
incobotulinumtoxinA
FDA Link
03/2014
1
Biomarkers (Surrogate Marker)
IBA
01/2013
1
C-Reactive Protein
IBA
01/2013
1
Ki-1 Antigen
IBA
01/2012
1
Neoplasm Antibodies
IBA
01/2010
1
scleroglucan
IBA
02/2009
1
Carcinoembryonic Antigen
IBA
04/2002
Therapy/Procedure
6
Therapeutics
01/2021 - 01/2010
4
Immunotherapy
01/2015 - 04/2002
2
Drug Therapy (Chemotherapy)
04/2014 - 01/2012
1
Radiotherapy
04/2014
1
Lasers (Laser)
01/2012